secwatch.observer — SEC 8-K summary
======================================

Issuer:     VITASPRING BIOMEDICAL CO. LTD. (—)
CIK:        0001697884
Form:       8-K
Filed at:   2025-08-11T23:59:59+00:00
Accession:  0001683168-25-005896
Event type: other_material
Sentiment:  negative
Materiality: 0.75
Item codes: 4.01, 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Auditor TAAD resigns; four directors/officers exit; Dr. Lai appointed CEO/CFO/Chair
--------------------------------------------------------------------------------

- TAAD LLP resigned as independent auditor effective Aug 5, 2025; no disagreements or reportable events.
- Effective Aug 7, 2025, Lin Jer-Li, Chen YenXun, Chu Pao-Chi, and Kao Cheng-Hsiang resigned from all positions.
- Dr. Ssu-Chuan Lai appointed Chairperson, CEO, and CFO effective Aug 7, 2025.
- Dr. Lai previously Vice General Manager at Biospring Medical, with cell manufacturing and regulatory expertise.
- Resignations were not due to any disagreements with the company's operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1697884/000168316825005896/0001683168-25-005896-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1697884/000168316825005896/vitaspring_8k.htm
  HTML page:      https://secwatch.observer/filing/0001683168-25-005896

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer